Literature DB >> 10715525

Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo.

D K Xing1, C Canthaboo, M J Corbel.   

Abstract

Macrophages from mice immunised with whole cell pertussis vaccine (WCV) responded in vitro to selected antigens by nitric oxide (NO) synthesis. This process was closely associated with macrophage activation. Because of the postulated role of traces of pertussis toxin (PT) in the protective effects of WCV, native PT and a genetically detoxified PT (g-PT) in combination with either a heat-treated whole cell pertussis vaccine (dWCV) or a three component acellular vaccine (ACV), were examined for their effects on NO induction in murine macrophages. The protective effects of these two forms of PT were examined in parallel using the intracerebral (ic) and aerosol challenge routes. Cultures of macrophages from mice immunised with dWCV and ACV, PT or g-PT produced less NO than comparable cultures from mice vaccinated with WCV. However, vaccination with either dWCV or ACV in combination with PT but not with g-PT, induced a significant increase (126-157%) in NO production by cultured cells and was associated with increased protection against challenge by both the ic and aerosol routes. These data indicate that a low concentration of PT acting as a co-factor in combination with other Bordetella pertussis antigens, can potentiate the activation of macrophages and that this process plays a key role in protection against infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10715525     DOI: 10.1016/s0264-410x(99)00562-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Investigation of role of nitric oxide in protection from Bordetella pertussis respiratory challenge.

Authors:  C Canthaboo; D Xing; X Q Wei; M J Corbel
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Relationship of immunogenicity to protective potency in acellular pertussis vaccines.

Authors:  Dorothy Xing; Catpagavalli Asokanathan; Ying Hua Xu; Barbara Bolgiano; Alex Douglas-Bardsley; Shumin Zhang; Junzhi Wang; Michael Corbel
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis.

Authors:  Catpagavalli Asokanathan; Michael Corbel; Dorothy Xing
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

4.  Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.

Authors:  L M Schaeffer; A A Weiss
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  High dose interleukin-12 exacerbates Bordetella pertussis infection and is associated with suppression of cell-mediated immunity in a murine aerosol challenge model.

Authors:  C R D Carter; B M Dagg; K M Whitmore; J R Keeble; C Asokanathan; D Xing; K B Walker
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

6.  c-di-GMP enhances protective innate immunity in a murine model of pertussis.

Authors:  Shokrollah Elahi; Jill Van Kessel; Tedele G Kiros; Stacy Strom; Yoshihiro Hayakawa; Mamoru Hyodo; Lorne A Babiuk; Volker Gerdts
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.